Related Experiment Video
Updated: Jun 18, 2026
04:41
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
Published on: March 10, 2023
Hepatocellular carcinoma and evidence-based surgery.
World Journal of Gastroenterology
|November 13, 2009
Summary
Liver transplantation is not the primary treatment for hepatocellular carcinoma (HCC). Further research is needed to compare transplantation, resection, and radio-frequency ablation for HCC.
Area of Science:
- Hepatobiliary surgery
- Transplant surgery
- Oncology
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Liver transplantation is a complex procedure with limited availability.
- Current treatment paradigms for HCC require critical evaluation.
Discussion:
- Transplantation is not universally the most effective treatment for hepatocellular carcinoma (HCC).
- In France, a very small percentage of HCC patients receive transplants.
- The benefit-to-risk ratio of various curative treatments for HCC needs rigorous assessment.
Key Insights:
- Transplantation is not the leading curative therapy for HCC.
- Limited patient access to liver transplantation for HCC.
- Need for comparative studies on HCC treatments.
Outlook:
- Future research should focus on randomized controlled trials.
- Comparative effectiveness research is crucial for optimizing HCC management.
- Evidence-based guidelines are needed to inform clinical practice for HCC.
